UNSPSC 51422329: Betamethasone sodium phosphate

This classification denotes a therapeutic glucocorticoid with the molecular formula C22H28FO8P.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7BK02SCL3W, chemically known as 9-fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl dihydrogen phosphate but more generally known as betamethasone sodium phosphate, which bears US NIH Compound Identifier 2367.

The base compound, Betamethasone, comes in many other forms, including base, acetate, acetate phosphate, acibutate, alcohol, benzoate, butyrate propionate, dihydrogen phosphate, dipropionate, phosphate, sodium, valerate, 17, 21-dipropionate, 17-acetate, 17 alpha-monopropionate, 17-benzoate, 17-dipropionate, 17-propionate, 17-propionate 21-methoxide, 17-valerate, 21-acetate, 21-disodium phosphate, 21-pentanoate, 21-phosphate, 21-phosphate disodium, and 21-valerate.

UNSPSC 51422329 Betamethasone sodium phosphate is a Commodity code that represents a specific pharmaceutical product — a corticosteroid used in medical and clinical settings. The recent state and local solicitation activity under this code does not reflect purchases of betamethasone sodium phosphate itself; instead, Seminole County, Florida posted an IFB for naloxone and safe drug deactivation systems, a mismatch between the code taxonomy and the work actually being solicited. State and local governments use pharmaceutical commodity codes to procure drugs for public health programs, emergency response, and clinical care, but the single recent opportunity on record involves opioid-reversal medication and drug disposal systems rather than the corticosteroid this code nominally describes.

Seminole County, Florida is the only issuing body with recent activity under this code designation. Seminole County Community Health posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to 520 W. Lake Mary Blvd, Sanford, Florida; the response deadline was July 26, 2023. The procurement required bids to include all shipping and delivery costs, with a two-year initial term and one-year renewal option, and noted potential FEMA funding and associated federal compliance requirements. The code shows minimal recent activity aligned with betamethasone sodium phosphate procurement; business development professionals should treat this code as a low-signal category for pharmaceutical product opportunities at the state and local level and verify code alignment in individual opportunities before pursuing.